Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension

Richard A Preston, James O. Coffey, Barry J Materson, Marlies Ledford, Alberto B. Alonso

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Uncontrolled severe hypertension is associated with alarming rates of cardiovascular events but the mechanisms of vascular injury are not well understood. Recent investigative interest has focused on platelet activation and platelet P-selectin (CD62P) as direct mediators of vascular inflammation and injury. We investigated the association of extreme blood pressure (BP) elevation with platelet P-selectin and fibrinolytic markers in high risk patients with severe hypertension. Methods: Cross-sectional comparison of platelet CD62, tissue plasminogen activator antigen (tPA), and plasminogen activator inhibitor-1 activity (PAI-1) among 3 BP groups: untreated severely hypertensive patients (SHT; n = 18), untreated mildly hypertensive patients (MHT; n = 19), and normotensive controls (NT; n = 16). Results: Platelet CD62 was greatest in SHT (p = 0.00008) and showed a strong correlation with both systolic (p = 0.0002, r = 0.52) and diastolic (p = 0.0003, r = 0.52) BP. tPA was greater in SHT than MHT or NT (ANOVA; p = 0.02) and correlated with diastolic BP but not SBP. PAI-1 did not correlate with either SBP or DBP but was related to body mass index, diabetes, and dyslipidemia. Conclusions: Platelet CD62 demonstrated a strong and graded association with both systolic and diastolic BP that persisted in the presence of multiple concomitant risk factors. The association of BP with CD62P was stronger than with either PAI-1 or tPA-Ag. Platelet activation and platelet CD62 increase in a BP-dependent manner and this relationship persists at extreme levels of BP. Platelet activation and platelet CD62 may participate in the accelerated target organ injury observed in high risk patients with severe hypertension.

Original languageEnglish
Pages (from-to)148-154
Number of pages7
JournalAtherosclerosis
Volume192
Issue number1
DOIs
StatePublished - May 1 2007

Fingerprint

P-Selectin
Platelet Activation
Blood Platelets
Blood Pressure
Hypertension
Plasminogen Activator Inhibitor 1
Tissue Plasminogen Activator
Vascular System Injuries
Antigens
Inflammation Mediators
Blood Group Antigens
Dyslipidemias
Analysis of Variance
Body Mass Index

Keywords

  • Endothelium-derived factors
  • Fibrinolysis
  • Hypertension
  • Plasminogen activators
  • Platelet activation
  • Platelet P-selectin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. / Preston, Richard A; Coffey, James O.; Materson, Barry J; Ledford, Marlies; Alonso, Alberto B.

In: Atherosclerosis, Vol. 192, No. 1, 01.05.2007, p. 148-154.

Research output: Contribution to journalArticle

Preston, Richard A ; Coffey, James O. ; Materson, Barry J ; Ledford, Marlies ; Alonso, Alberto B. / Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. In: Atherosclerosis. 2007 ; Vol. 192, No. 1. pp. 148-154.
@article{813190dd2bae4a25b11a4c310fb0828a,
title = "Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension",
abstract = "Background: Uncontrolled severe hypertension is associated with alarming rates of cardiovascular events but the mechanisms of vascular injury are not well understood. Recent investigative interest has focused on platelet activation and platelet P-selectin (CD62P) as direct mediators of vascular inflammation and injury. We investigated the association of extreme blood pressure (BP) elevation with platelet P-selectin and fibrinolytic markers in high risk patients with severe hypertension. Methods: Cross-sectional comparison of platelet CD62, tissue plasminogen activator antigen (tPA), and plasminogen activator inhibitor-1 activity (PAI-1) among 3 BP groups: untreated severely hypertensive patients (SHT; n = 18), untreated mildly hypertensive patients (MHT; n = 19), and normotensive controls (NT; n = 16). Results: Platelet CD62 was greatest in SHT (p = 0.00008) and showed a strong correlation with both systolic (p = 0.0002, r = 0.52) and diastolic (p = 0.0003, r = 0.52) BP. tPA was greater in SHT than MHT or NT (ANOVA; p = 0.02) and correlated with diastolic BP but not SBP. PAI-1 did not correlate with either SBP or DBP but was related to body mass index, diabetes, and dyslipidemia. Conclusions: Platelet CD62 demonstrated a strong and graded association with both systolic and diastolic BP that persisted in the presence of multiple concomitant risk factors. The association of BP with CD62P was stronger than with either PAI-1 or tPA-Ag. Platelet activation and platelet CD62 increase in a BP-dependent manner and this relationship persists at extreme levels of BP. Platelet activation and platelet CD62 may participate in the accelerated target organ injury observed in high risk patients with severe hypertension.",
keywords = "Endothelium-derived factors, Fibrinolysis, Hypertension, Plasminogen activators, Platelet activation, Platelet P-selectin",
author = "Preston, {Richard A} and Coffey, {James O.} and Materson, {Barry J} and Marlies Ledford and Alonso, {Alberto B.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1016/j.atherosclerosis.2006.04.028",
language = "English",
volume = "192",
pages = "148--154",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension

AU - Preston, Richard A

AU - Coffey, James O.

AU - Materson, Barry J

AU - Ledford, Marlies

AU - Alonso, Alberto B.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Background: Uncontrolled severe hypertension is associated with alarming rates of cardiovascular events but the mechanisms of vascular injury are not well understood. Recent investigative interest has focused on platelet activation and platelet P-selectin (CD62P) as direct mediators of vascular inflammation and injury. We investigated the association of extreme blood pressure (BP) elevation with platelet P-selectin and fibrinolytic markers in high risk patients with severe hypertension. Methods: Cross-sectional comparison of platelet CD62, tissue plasminogen activator antigen (tPA), and plasminogen activator inhibitor-1 activity (PAI-1) among 3 BP groups: untreated severely hypertensive patients (SHT; n = 18), untreated mildly hypertensive patients (MHT; n = 19), and normotensive controls (NT; n = 16). Results: Platelet CD62 was greatest in SHT (p = 0.00008) and showed a strong correlation with both systolic (p = 0.0002, r = 0.52) and diastolic (p = 0.0003, r = 0.52) BP. tPA was greater in SHT than MHT or NT (ANOVA; p = 0.02) and correlated with diastolic BP but not SBP. PAI-1 did not correlate with either SBP or DBP but was related to body mass index, diabetes, and dyslipidemia. Conclusions: Platelet CD62 demonstrated a strong and graded association with both systolic and diastolic BP that persisted in the presence of multiple concomitant risk factors. The association of BP with CD62P was stronger than with either PAI-1 or tPA-Ag. Platelet activation and platelet CD62 increase in a BP-dependent manner and this relationship persists at extreme levels of BP. Platelet activation and platelet CD62 may participate in the accelerated target organ injury observed in high risk patients with severe hypertension.

AB - Background: Uncontrolled severe hypertension is associated with alarming rates of cardiovascular events but the mechanisms of vascular injury are not well understood. Recent investigative interest has focused on platelet activation and platelet P-selectin (CD62P) as direct mediators of vascular inflammation and injury. We investigated the association of extreme blood pressure (BP) elevation with platelet P-selectin and fibrinolytic markers in high risk patients with severe hypertension. Methods: Cross-sectional comparison of platelet CD62, tissue plasminogen activator antigen (tPA), and plasminogen activator inhibitor-1 activity (PAI-1) among 3 BP groups: untreated severely hypertensive patients (SHT; n = 18), untreated mildly hypertensive patients (MHT; n = 19), and normotensive controls (NT; n = 16). Results: Platelet CD62 was greatest in SHT (p = 0.00008) and showed a strong correlation with both systolic (p = 0.0002, r = 0.52) and diastolic (p = 0.0003, r = 0.52) BP. tPA was greater in SHT than MHT or NT (ANOVA; p = 0.02) and correlated with diastolic BP but not SBP. PAI-1 did not correlate with either SBP or DBP but was related to body mass index, diabetes, and dyslipidemia. Conclusions: Platelet CD62 demonstrated a strong and graded association with both systolic and diastolic BP that persisted in the presence of multiple concomitant risk factors. The association of BP with CD62P was stronger than with either PAI-1 or tPA-Ag. Platelet activation and platelet CD62 increase in a BP-dependent manner and this relationship persists at extreme levels of BP. Platelet activation and platelet CD62 may participate in the accelerated target organ injury observed in high risk patients with severe hypertension.

KW - Endothelium-derived factors

KW - Fibrinolysis

KW - Hypertension

KW - Plasminogen activators

KW - Platelet activation

KW - Platelet P-selectin

UR - http://www.scopus.com/inward/record.url?scp=34247138810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247138810&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2006.04.028

DO - 10.1016/j.atherosclerosis.2006.04.028

M3 - Article

C2 - 16764881

AN - SCOPUS:34247138810

VL - 192

SP - 148

EP - 154

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -